Startups

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

1 day ago   |   Xconomy   |   4 articles

A year ago about 40,000 people gathered in Chicago for the annual meeting of the American Society of Clinical Oncology. Today a virtual version of the ASCO conference, the...
Read more ...

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

1 day ago   |   Xconomy

Human DNA holds secrets that, once uncovered, have led scientists to develop a number of treatments for disease. A slew of biopharmas and biotechs-not to mention national...
Read more ...

AbCellera Raises $105M to Advance Antibody Discovery Operations

AbCellera Raises $105M to Advance Antibody Discovery Operations

2 days ago   |   Xconomy

Most of the best-selling drugs worldwide today are antibodies, and in the three decades-plus since the first such drug was approved, makers of such treatments have begun...
Read more ...

Startup targets glioblastoma tumors with CAR-T therapy

3 days ago   |   Fierce Biotech

Startup targets glioblastoma tumors with CAR-T therapy aliu Wed, 05/27/2020 - 06:32
Read more ...

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

3 days ago   |   Xconomy

A stem cell biologist, a gene editing expert, and a data engineer walk into a room...and that's just a few of the people Daphne Koller has recruited in the past two years to...
Read more ...

COVID-19 Sparks New Opportunities for Digital Health Companies

COVID-19 Sparks New Opportunities for Digital Health Companies

4 days ago   |   Xconomy

Clinicians and regulators are rethinking how healthcare is provided amid precautions prompted by COVID-19. In-person physician visits don't fit within the physical distancing...
Read more ...

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

4 days ago   |   Xconomy

Privately held biotech ViaCyte has banked $27 million, the majority an installment of cash from a tranched $80 million Series D financing round it closed in late 2018. The...
Read more ...

Carlsbad's ChromaCode raises $38 million to pursue low-cost testing platform for coronavirus

8 days ago   |   San Diego Biotechnology

Startup has licensed technology out of Cal Tech that delivers more information from molecular medical lab tests ...
Read more ...

Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche's Protein Play & More

Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche's Protein Play & More

8 days ago   |   Xconomy

As the nation started to reopen this week following two months of closed businesses and stay-at-home orders, public health officials and economists cautioned that society won't...
Read more ...

Scientists Use Virtual Reality to Refine New AI-Generated Drugs for COVID-19

9 days ago   |   San Diego Biotechnology

SAN DIEGO, May 21, 2020 /PRNewswire/ - Nanome, Inc., a virtual reality startup whose signature product is a computational chemistry software platform, has co-authored a paper...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

Forma Therapeutics has developed a pipeline of small molecules aimed at rare blood disorders and cancers, but it aims to advance two-investigational treatments for sickle cell... Read more ...

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem's Approval & More

A year ago about 40,000 people gathered in Chicago for the annual meeting of the American Society of Clinical Oncology. Today a virtual version of the ASCO conference, the... Read more ...

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

An AbbVie drug that treats pain in the uterus has notched an additional FDA approval for addressing heavy menstrual bleeding associated with uterine fibroids. The regulatory... Read more ...

Daya Bay Reactor Experiment Continues to Generate Data

Daya Bay Reactor Experiment Continues to Generate Data

Antineutrino detectors are submersed in liquid at the Daya Bay experiment, as seen during the final phase of construction in August 2012. Experiment: Daya Bay reactor neutrino... Read more ...

Seeing Cancer, But Not Through a Microscope

Seeing Cancer, But Not Through a Microscope

Toward the end of the 19th century, a French doctor named Ernest Besnier coined the term “ biopsy ,” combining the Greek bios and opsis. In the decades since, clinicians have... Read more ...

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

Human DNA holds secrets that, once uncovered, have led scientists to develop a number of treatments for disease. A slew of biopharmas and biotechs-not to mention national... Read more ...

Don't Wait for “Them” to Find Your Weaknesses

Don't Wait for “Them” to Find Your Weaknesses

Our Professional Services Written by: Crystal Booth, M.M.- Regional Manager, Southeast USA at PSC Biotech We've probably all heard the phrase “audit ready state”. But what does... Read more ...

RTRIP: a comprehensive profile of transposon insertion polymorphisms in rice

Abstract Transposable elements , also known as transposons, a type of mobile genetic elements, are widespread across all investigated eukaryotic organisms and typically... Read more ...

Functional oral nanoparticles for delivering silibinin and cryptotanshinone...

Breast cancer lung metastasis occurs in more than 60% of all patients with breast cancer, and most of those afflicted by it eventually die of recurrence. The tumor... Read more ...

Escherichia coli metabolism under short-term repetitive substrate dynamics...

Microbial metabolism is highly dependent on the environmental conditions. Especially, the substrate concentration, as well as oxygen availability, determine the metabolic... Read more ...